We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Copan Expands US Manufacturing Operations with Multimillion Dollar Investment

By LabMedica International staff writers
Posted on 03 Sep 2009
Print article
Copan Diagnostics, Inc. (Murrieta, CA, USA) is undertaking a new multimillion US dollar investment project to bring plastic transfer pipette and additional medical device manufacturing operations to its California, USA facility.

Plastic transfer pipettes are essential products widely used by hospital and other laboratories for transferring liquids and clinical samples during diagnostics testing or analytical research. As many as 500 million pipettes are used in the United States annually. Copan developed a customized blow molding equipment that maximizes productivity through a fully automated system for separating the molded product from waste material, which is then 100% recycled.

A 1208 m2 building adjacent to its current facility was purchased by Copan to house new plastic blow molding equipment that is used to manufacture transfer pipettes. The new building allows the transfer of some activities from its current location, thus allowing more space for Copan to expand medical device manufacturing operations for the company's microbiology specimen collection and transport line.

The project is an integral part of Copan's plan to support future demand. Norman Sharples, executive vice president at Copan Diagnostics, said, "in today's market, companies must examine opportunities to bring further efficiencies to their operations to remain competitive, which is what we are doing with this endeavor."

Copan Diagnostics manufactures collection and transport systems and offers a complete range of microbial sampling products for traditional culture analysis and molecular diagnostic assays. The company also produces flocked swabs, universal transport medium, the ESwab and other laboratory consumables. The Walk-Away Specimen Processor (WASP), a system for automatic planting and streaking of microbiology samples, is another Copan product.

Related Links:
Copan Diagnostics, Inc.



Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
FLU/RSV Test
Humasis FLU/RSV Combo
New
Human Insulin CLIA
Human Insulin CLIA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.